Illumina (ILMN) Research & Development (2009 - 2026)

Illumina has reported Research & Development for 18 years, with the latest figure at $252.0 million in Q2 2026.

• Research & Development for Q2 2026 came in at $252.0 million, up 2.02% year-over-year; the trailing twelve-month figure through Jun 2026 was $960.0 million (down 4.76% YoY), and the FY2025 annual result was $967.0 million, down 17.28% from the prior year.
• Research & Development advanced to $252.0 million in Q2 2026, from $240.0 million in the prior quarter.
• Over five years, Research & Development peaked at $486.0 million in Q1 2023 and troughed at $229.0 million in Q3 2025.
• A 5-year average of $302.7 million and a median of $319.0 million in 2022 frame the typical range for Research & Development.
• The widest annual swing landed in 2022, when Research & Development surged 63.96%; it then slipped 29.84% in 2023.
• A 5-year view of Research & Development shows it stood at $325.0 million in 2022, then rose by 4.92% to $341.0 million in 2023, then retreated by 24.93% to $256.0 million in 2024, then fell by 6.64% to $239.0 million in 2025, then gained by 5.44% to $252.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $252.0 million in Q2 2026, $240.0 million in Q1 2026, and $239.0 million in Q4 2025.